Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boswellic acid in acute ischemic stroke
IRCT20231015059724N1Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of boswellic acid in ischemic stroke, sponsored by Urmia University of Medical Sciences. Started Nov 2023; status: completed.
02
Drugs
boswellic acid
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on IRCT20231015059724N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231015059724N1.